A detailed history of Jefferies Financial Group Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 336,000 shares of ADMA stock, worth $3.76 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
336,000
Previous 2,260,000 85.13%
Holding current value
$3.76 Million
Previous $10.2 Million 78.3%
% of portfolio
0.02%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$4.4 - $6.74 $8.47 Million - $13 Million
-1,924,000 Reduced 85.13%
336,000 $2.22 Million
Q4 2023

Feb 13, 2024

BUY
$3.08 - $4.52 $6.96 Million - $10.2 Million
2,260,000 New
2,260,000 $10.2 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.2B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.